Dr. Ian Lewis is an assistant professor and Alberta Innovates – Health Solutions Translational Health Chair in Metabolomics in the Department of Biological Sciences at the University of Calgary. Lewis earned a PhD in biochemistry from the University of Wisconsin-Madison and completed his postdoctoral training at Princeton University.
He was recruited by UCalgary to launch a research program that harnesses state-of-the-art technology to detect and combat infectious diseases. As a part of this program, Lewis built the Calgary Metabolomics Research Facility (CMRF), an analytical lab that specializes in unravelling the complex host-pathogen metabolic interactions that occur during infections.
Recently, he partnered with Alberta Public Laboratories (formerly Calgary Laboratory Services [CLS]) to launch a suite of new diagnostic tools and treatment practices that may significantly reduce the number of people who die from infections.
Dr. Church is dually trained as an infectious diseases and medical microbiology specialist, and is currently a professor in both the Department of Pathology & Laboratory Medicine, and the Department of Medicine at University of Calgary’s Cumming School of Medicine.
She is the Section Chief, Microbiology, South Hub for Alberta Public Laboratories (formerly Calgary Laboratory Services [CLS]). Dr. Church enjoys practicing from bedside to bench and back because of the constant evolution of our understanding of pathogens and their interaction with the host.
As the medical administrator of a large corporate laboratory division, she was involved in regional laboratory restructure in the Calgary Zone from the inception of CLS in 1996, and directed the implementation of a single centralized regional clinical microbiology service for an urban/rural population of ~1.5 million people.
This experience made her comfortable dealing with constant practice and system change, and the challenges of working within a large publically funded healthcare jurisdiction. She has published more than 400 peer-reviewed manuscripts, abstracts, book chapters and review articles.
She has also been an author and Section Editor for the 4th Ed., Clinical Microbiology Procedures Handbook, ASM Press, and co-author for the 7th Ed., Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, Wolters Kluwer. Much of Dr. Church’s clinical research has focussed on two of the biggest global infection challenges—antibiotic resistant organisms, and the development and implementation of advanced technology.
Dr. Noskov is a professor of Biophysical and Computational Chemistry with the Centre for Molecular Simulations and Associate Head (Research) with the Department of Biological Sciences, University of Calgary.
He completed his graduate training in physical chemistry at the ISC (Russian Academy of Sciences), and the University of Innsbruck, for which he was supported by a European Union graduate scholarship. He received post-doctoral training as an American Epilepsy Foundation Fellow at the Department of Biochemistry and Structural Biology, Weill Medical College of Cornell University, in the laboratory of Benoit Roux.
In 2005, he joined the newly-formed Institute for Molecular Pediatric Sciences at the University of Chicago as a staff scientist before starting his own lab at the University of Calgary in 2006. Sergei’s lab combines computational and experimental biology to untangle structure-function relations in complex biological systems. Research communications from his lab have appeared in publications such as Nature, Molecular Cell, PNAS, Journal of Biological Chemistry, and other field leading journals.
Sergei is an Associate Editor for BBA-Biomembranes, Frontiers in Pharmacology (Ion Channels and Channelopathies section) and BMC Toxicology and Pharmacology. Dr. Noskov has been recognized with multiple awards including the CIHR New Investigator Award (Canada), the AIF New Faculty Award (Canada), INTAS Young Scientist Award (European Union), and the American Epilepsy Foundation Post-Doctoral Fellowship Award (USA), and has been recognized as an Alberta Heritage Foundation for Medical Research Scholar.
Noskov is an active member of HPC community, both in Canada and world-wide, serving as a grant panel member for the National Academy of Sciences USA, Special Program Panel (ANTON2), and participating in the Science Leadership Council of Compute Canada. Dr. Noskov provides oversight of the informatics-driven platforms being developed as part of the LSARP project.
Ashlee M. Earl is a research scientist and senior group leader for the Bacterial Genomics Group at the Broad Institute of MIT and Harvard, where she is an institute scientist.
Within the Broad Institute’s Genomic Center for Infectious Diseases and Infectious Disease and Microbiome Program, Earl is working to understand the relationship between microbes and human health including how multi-drug resistant pathogens emerge and spread.
Earl coordinated much of the Broad’s research in the Human Microbiome Project and now leads a team of computational biologists to develop and utilize an array of ‘omics analytical approaches to dissect bacterial and host contributions to several infectious diseases.
She has organized and led dozens of local and international collaborations to bring genomic approaches to the study of tuberculosis, urinary tract infections, and hospital-acquired infections caused by enterococci and carbapenem-resistant Enterobacteriaceae.
Dr. Fiona Clement is an Associate Professor within the Cumming School of Medicine at the University of Calgary and Director of the Health Technology Assessment Unit within the O’Brien Institute of Public Health.She has extensive training in health economics and health policy. She has published a career total of 100 peer-reviewed publications, 30 policy reports, and has obtained over $20 million dollars in funding ($3.0 million as PI).
She has been awarded numerous national awards recognizing her outstanding contributions to health economics and policy including the Harkness Fellowship in Health Care Policy and Practice, the Maurice McGregor Award for excellence and outstanding leadership in Health Technology Assessment, and has been named to Calgary’s Top 40 Under 40. Most recently, Dr. Clement supported the Alberta Government by completing a major policy analysis to develop an evidence-informed cannabis framework.
Dr. Naugler is a professor and Department Head in the Department of Pathology and Laboratory Medicine at the Cuming School of Medicine at the University of Calgary.
He is the Medical Director of Alberta Public Laboratory, South Sector, and he holds cross appointments in the Departments of Family Medicine and Community Health Sciences.
He completed medical training at Dalhousie University, followed by family medicine training at Western University (CCFP 1999, FCFP 2010), and specialty training in general pathology at Dalhousie University (FRCPC 2009).
A recognized expert in the field of pathology informatics, Dr. Naugler is the author of approximately 170 peer-reviewed publications and holds a CIHR Foundation Scheme grant for his work on laboratory utilization management.
He was the winner of the 2013 University of Calgary Cumming School of Medicine Watanabe Distinguished Achievement Award for Overall Excellence. His research includes work on laboratory test appropriateness, clinical epidemiology, and big data approaches to predictive algorithm development.
Dr. Yonatan Grad, MD, PhD is the Melvin J. and Geraldine L. Glimcher Assistant Professor in the Department of Immunology and Infectious Diseases at the Harvard TH Chan School of Public Health, and an attending physician in the Division of Infectious Diseases at Brigham and Women’s Hospital.
He earned his MD and PhD at Harvard Medical School, trained in internal medicine at BWH and infectious diseases at BWH and Massachusetts General Hospital.
He did his postdoctoral work at the Center for Communicable Disease Dynamics at the Chan School. The Grad laboratory studies how pathogens evolve and spread through populations with the motivation of improving clinical and public health strategies for decreasing the burden of disease, with a particular focus on antibiotic resistance.
His lab uses a variety of methods, including genomics, epidemiological tools, and microbiology to define the dynamics of spread and characterize the genotypic and phenotypic diversity of the pathogens.
For further information please contact:
For all media inquiries please contact: